Imipramine Hydrochloride
NDC Package 50436-2022-2
Package Information
Imipramine Hydrochloride is depression-For the relief of symptoms of depression. Endogenous depression is more likely to be alleviated than other depressive states. One to three weeks of treatment may be needed before optimal therapeutic effects are evident.Childhood Enuresis-May be useful as temporary adjunctive therapy in reducing enuresis in children aged 6 years and older, after possible organic causes have been excluded by appropriate tests. In patients having daytime symptoms of frequency and urgency, examination should include voiding cystourethrography and cystoscopy, as necessary. Marketed by Unit Dose Services, this product is identified by NDC 50436-2022 and is authorized under FDA application ANDA040751.
Identification & Billing
- RxCUI: 835564 - imipramine HCl 25 MG Oral Tablet
- RxCUI: 835564 - imipramine hydrochloride 25 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 50436 - Unit Dose Services
- 50436-2022 - Imipramine Hydrochloride
- 50436-2022-2 - 60 TABLET, FILM COATED in 1 BOTTLE
- 50436-2022 - Imipramine Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (50436-2022). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 50436-2022-2 identifies a specific commercial package of 60 tablet, film coated in 1 bottle of Imipramine Hydrochloride, labeled by Unit Dose Services. This product is billed for "EA" each discreet unit and contains an estimated amount of 60 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Unit Dose Services on July 18, 2022. The current certification is valid through December 31, 2023.
How is this Unit Dose Services product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 50436202202. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.